Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
15 May 2020
Historique:
received: 29 10 2019
revised: 11 02 2020
accepted: 21 02 2020
pubmed: 26 2 2020
medline: 8 1 2021
entrez: 26 2 2020
Statut: ppublish

Résumé

Brain microglia cells are responsible for recognizing foreign bodies and act by activating other immune cells. Microglia react against infectious agents that cross the blood-brain barrier and release pro-inflammatory cytokines including interleukin (IL)-1β, IL-33 and tumor necrosis factor (TNF). Mast cells (MCs) are immune cells also found in the brain meninges, in the perivascular spaces where they create a protective barrier and release pro-inflammatory compounds, such as IL-1β, IL-33 and TNF. IL-1β binds to the IL-1R1 receptor and activates a cascade of events that leads to the production of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and activation of the immune system. IL-33 is a member of the IL-1 family expressed by several immune cells including microglia and MCs and is involved in innate and adaptive immunity. IL-33 is a pleiotropic cytokine which binds the receptor ST2 derived from TLR/IL-1R super family and is released after cellular damage (also called "alarmin"). These cytokines are responsible for a number of brain inflammatory disorders. Activated IL-1β in the brain stimulates microglia, MCs, and perivascular endothelial cells, mediating various inflammatory brain diseases. IL-37 also belongs to the IL-1 family and has the capacity to suppress IL-1β with an anti-inflammatory property. IL-37 deficiency could activate and enhance myeloid differentiation (MyD88) and p38-dependent protein-activated mitogenic kinase (MAPK) with an increase in IL-1β and IL-33 exacerbating neurological pathologies. In this article we report for the first time that microglia communicate and collaborate with MCs to produce pro-inflammatory cytokines that can be suppressed by IL-37 having a therapeutic potentiality.

Identifiants

pubmed: 32097657
pii: S0014-2999(20)30127-8
doi: 10.1016/j.ejphar.2020.173035
pii:
doi:

Substances chimiques

Cytokines 0
IL37 protein, human 0
Inflammation Mediators 0
Interleukin-1 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

173035

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Pio Conti (P)

Postgraduate Medical School, University of Chieti, Chieti, Italy. Electronic address: pconti@unich.it.

Dorina Lauritano (D)

University of Milan-Bicocca, Medicine and Surgery Department, Centre of Neuroscience of Milan, Italy. Electronic address: dorina.lauritano@unimib.it.

Alessandro Caraffa (A)

School of Pharmacy, University of Camerino, Camerino, Italy. Electronic address: alecaraffa@libero.it.

Carla Enrica Gallenga (CE)

Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, Ferrara, Italy. Electronic address: gllcln@unife.it.

Spiros K Kritas (SK)

Department of Microbiology and Infectious Diseases, School of Veterinary Medicine, Aristotle University of Thessaloniki, Macedonia, Greece. Electronic address: skritas@vet.auth.gr.

Gianpaolo Ronconi (G)

Clinica dei Pazienti del Territorio, Fondazione Policlinico Gemelli, Rome, Italy. Electronic address: gianpaolo.ronconi@policlinicogemelli.it.

Stefano Martinotti (S)

Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy. Electronic address: stefano.martinotti@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH